The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
let it settle down first see where they take it then buy in.
I did see that, but say 4.5m a year revenue, should still be much higher than this.
Purely on a p/e multiple this should be nearer £2.50
Its over 6 years though so don't get to hung up on it, yes great contract but the mm's have pushed it up to quick.
Massively undervalued on this. Should easily clear £2 today imo.
£10m MCAP + £26.5m contract win.
Market really likes this news. Looks like Tom Winnifrith got this wrong. "Croma Security Solutions Group Plc is delighted to announce a very significant contract win. The contract with a major UK local authority is the largest the group has ever won. The 6 year contract for the provision of a range of security services is worth £27m in total. Sebastian Morley Chairman of CSSG comments: "This contract award is extremely significant and is the largest that the Group has won to date. It is a testament to the unique offering that Croma Vigilant brings to the market. The ex-military ethos of the business is resonating strongly with both our clients and our staff; majoring on discipline, operational excellence and continuity. We are delighted with this award and its effect upon the Group's development. We look forward to updating the market further in the new calendar year.""
But mm's taking the pee.
here but intrigued... Anyone have any thoughts of where this might go?
@TruroTrader, Thanks, and having held off I'm relieved to see I've stayed out of a significant pullback.
Me neither - the shops were always a week link IMO and the previous purchase was an attempt to build them up. I always thought that the reason they were never a good profit stream was the lack of a High Street demand for a specialised service. Security is not a walk in requirement.
when directors leave with immediate effect...
44.5 to buy.
Let me know when lol !!
tempting
again...
Getting to interesting levels??
still pretty hefty EV/EBIT
Hi AL75, not to sure if it is a buy as I've sold a couple of slices earlier this year to cement profits but I'm still in as the company does actually make profits and pays dividends( albeit both small) However in spite of the recent price rise in the last few months the MK is still only half its revenue so a definite hold for me. Previous Vigilante contracts still have a bit extra to add to revenue though they are low margin. But its FastVein that could be a good revenue booster if it actually gets taken up and why I am still here. Not expecting fireworks but hopefully the MK will rise if the revenue does. Hope that helps
I'm running the slide rule over Croma. Does anyone have any good points why its a buy at this price?
Wrong was you
no-one else noticed this yet?
I'm a little uncertain here. I originally was a vigilante share holder until the merger and I have topped up a little since but it seems to me that it is vigilante that is doing all the heavy lifting. Fastvein has not really performed as the hype would have it. The locksmith shops don't really seem to be expanding with any real pace and it's alright saying that there is not a lot of competition around but maybe that's because there not a lot of business either. I'm disappointed that not only was there no January divi but no explanation of why not. I also am not to happy with the fact that it takes em some 5 months or so to announce results. Perhaps the above is why the MK is so low. Am I just a pessimist or what?
to tiny residual (free carry) ...bounce over(done) imv
Thanks Beamer, I must remember to check out the Reach notices in future! Cheers.